Familial occurrence of abnormalities of high-density lipoprotein cholesterol

Journal of Clinical Lipidology

Volumn 1, Issue 1, 2007, Pages 31-40

  Kral, Brian G ^a   Becker, Diane M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Apolipoprotein A I; ATP binding cassette transporter A I; Cholesteryl ester transfer protein; Coronary artery disease; HDL cholesterol; Hepatic lipase; LDL cholesterol; Lecithin cholesterol acyltransferase; Lipoprotein lipase; Scavenger receptor class B type I; Very low density lipoprotein cholesterol

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; BEHAVIOR; CORONARY ARTERY DISEASE; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FAMILY; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; GENETIC REGULATION; GENETIC TRAIT; HEART PROTECTION; HERITABILITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPOLIPOPROTEINEMIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RISK ASSESSMENT; TANGIER DISEASE; TWINS;

EID: 34247899094     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2007.01.006     Document Type: Article

References (126)

1. Genest J.J., Martin-Munley S.S., McNamara J.R., et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85 (1992) 2025-2033
2. Prenger V.L., Beaty T.H., and Kwiterovich P.O. Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catheterization patients. Am J Hum Genet 51 (1992) 1047-1057
3. Heller D.A., de Faire U., Pedersen N.L., Dahlen G., and McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328 (1993) 1150-1156
4. Knoblauch H., Bauerfeind A., Krahenbuhl C., et al. Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population. Hum Mol Genet 11 (2002) 1477-1485
5. Hasstedt S.J., Albers J.J., Cheung M.C., et al. The inheritance of high density lipoprotein cholesterol and apolipoprotein A-I and A-II. Atherosclerosis 51 (1984) 21-29
6. Steinmetz J., Boerwinkle E., Gueguen R., Visvikis S., Henny J., and Siest G. Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis 92 (1992) 219-227
7. Wang X., and Paigen B. Genetics of variation in HDL cholesterol in humans and mice. Circ Res 96 (2005) 27-42
8. O'Connell D.L., Heller R.F., Roberts D.C., et al. Twin study of genetic and environmental effects on lipid levels. Genet Epidemiol 5 (1988) 323-341
9. Namboodiri K.K., Kaplan E.B., Heuch I., et al. The Collaborative Lipid Research Clinics Family Study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol 2 (1985) 227-254
10. Comuzzie A.G., Rainwater D.L., Blangero J., et al. Shared and unique genetic effects among seven HDL phenotypes. Arterioscler Thromb Vasc Biol 17 (1997) 859-864
11. Beekman M., Heijmans B.T., Martin N.G., et al. Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res 5 (2002) 87-97
12. Heller D.A., de Faire U., Pedersen N.L., Dahlen G., and McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328 (1993) 1150-1156
13. Austin M.A., King M.C., Bawol R.D., Hulley S.B., and Friedman G.D. Risk factors for coronary heart disease in adult female twins: Genetic heritability and shared environmental influences. Am J Epidemiol 125 (1987) 308-318
14. Williams R.R., Hunt S.C., Hopkins P.N., et al. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens 6 (1993) 319S-327S
15. Pollin T.I., Hsueh W.C., Steinle N.I., Snitker S., Shuldiner A.R., and Mitchell B.D. A genome-wide scan of serum lipid levels in the Old Order Amish. Atherosclerosis 173 (2004) 89-96
16. Gartside P.S., Khoury P., and Glueck C.J. Determinants of high density lipoprotein cholesterol in blacks and whites: the Second National Health and Nutrition Examination Survey. Am Heart J 108 (1984) 641-653
17. Van Tol A., and Hendriks H.F. Moderate alcohol consumption: effects on lipids and cardiovascular disease risk. Curr Opin Lipidol 12 (2001) 19-23
18. Hannuksela M., Marcel Y.L., Kesaniemi Y.A., and Savolainen M.J. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 33; (1992) 737-744
19. Criqui M.H., Wallace R.B., Heiss Mishkel M., Schonfeld G., and Jones G.T. Cigarette smoking and plasma high density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation 62 (1980) IV70-IV76
20. Howell W.H., McNamara D.J., Tosca M.A., Smoth B.T., and Gaines J.A. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta analysis. Am J Clin Nutr 65 (1997) 1747-1764
21. Ginsberg H.N. Nonpharmacologic management of low levels of high-density lipoprotein cholesterol. Am J Cardiol 86 (2000) 41L-45L
22. Leon A.S., and Connett J. Physical activity and 10.5 year mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Int J Epidemiol 20 (1991) 690-697
23. Durstine J.L., and Haskell W.L. Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 22 (1994) 477-521
24. Krummel D., Etherton T.D., Peterson S., and Kris-Etherton P.M. Effects of exercise on plasma lipids and lipoproteins of women. Proc Soc Exp Biol Med 204 (1993) 123-137
25. Haffner S.M., Applebaum-Bowden D., Wahl P.W., et al. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity. Arteriosclerosis 5 (1985) 169-177
26. Cutri B.A., Hime N.J., and Nicholls S.J. High-density lipoproteins: an emerging target in the prevention of cardiovascular disease. Cell Res 16 (2006) 799-808
27. Barter P., Kastelein J., Nunn A., Hobbs R., and Future Forum Editorial Board. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 168 (2003) 195-211
28. Morabia A., Cayanis E., Costanza M.C., et al. Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors. Hum Mol Genet 12 (2003) 2733-2743
29. Kareinen A., Viitanen L., Halonen P., Lehto S., and Laakso M. Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease. Arterioscler Thromb Vasc Biol 21 (2001) 1346-1352
30. Kort E.N., Ballinger D.G., Ding W., et al. Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23. Am J Hum Genet 66 (2000) 1845-1856
31. Mahaney M.C., Blangero J., Comuzzie A.G., VandeBerg J.L., Stern M.P., and MacCluer J.W. Plasma HDL cholesterol, triglycerides, and adiposity. A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study. Circulation 92 (1995) 3240-3248
32. Assmann G., von Eckardstein A., and Funke H. High density lipoproteins, reverse transport of cholesterol, and coronary heart disease. Insights from mutations. Circulation 87 (1993) III28-III34
33. Navab M., Ananthramaiah G.M., Reddy S.T., et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45 (2004) 993-1007
34. Cohen J.C., Kiss R.S., Pertsemlidis A., Marcel Y.L., McPherson R., and Hobbs H.H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
35. Costanza M.C., Cayanis E., Ross B.M., et al. Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population. Am J Epidemiol 161 (2005) 714-724
36. Heijmans B.T., Beekman M., Putter H., et al. Meta-analysis of four new genome scans for lipid parameters and analysis of positional candidates in positive linkage regions. Eur J Hum Genet 13 (2005) 1143-1153
37. Xu J.F., Prenger V.L., Coresh J., and Beaty T.H. Two-locus and bivariate segregation analysis of HDL-C and apo AI. Genet Epidemiol 10 (1993) 605-610
38. Juo S.H., Beaty T.H., Xu J., Prenger V.L., Coresh J., and Kwiterovich Jr. P.O. Segregation analysis of two-locus models regulating apolipoprotein-A1 levels. Genet Epidemiol 15 (1998) 73-86
39. Breslow J.L. Familial disorders of high-density lipoprotein metabolism. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Basis of Inherited Disease. 7th ed. (1995), McGraw Hill, New York 2031-2052
40. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
41. Walldius G., and Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 255 (2004) 188-205
42. Barbaras R., Puchois P., Fruchart J.C., and Ailhaud G. Cholesterol efflux from cultured adipose tissue cells is mediated by LpA-I particles but not by LpA-I:A-II particles. Biochem Biophys Res Commun 142 (1987) 63-69
43. Breslow J.L., Ross D., McPherson J., et al. Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc Natl Acad Sci U S A 79 (1982) 6861-6865
44. Von Eckardstein A. Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis 186 (2006) 231-239
45. Huang W., Sasaki J., Matsunaga A., et al. A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency. Arterioscler Thromb Vasc Biol 18; (1998) 389-396
46. Dastani Z., Dangoisse C., Boucher B., et al. A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians. Atherosclerosis 185 (2006) 127-136
47. Franceschini G., Sirtori C.R., Capurso II A., Weisgraber K.H., and Mahley R.W. A-I Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 66 (1980) 892-900
48. Franceschini G., Calabresi L., Tosi C., et al. Correlation between high density lipoprotein subclass distribution and triglyceridemia. Arteriosclerosis 7 (1987) 426-435
49. Nissen S.E., Tsunoda T., Tuzcu E.M., et al. Effect of recombinant Apo A-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
50. Ameli S., Hultgardh-Nilsson A., Cercek B., et al. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation 90 (1994) 1935-1941
51. Shah P.K., Yano J., Reyes O., et al. High dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice. Potential implications for acute plaque stabilization. Circulation 103 (2001) 3047-3050
52. Calabresi L., Pisciotta C.A., et al. The molecular basis of lecithin: cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25 (2005) 1972-1978
53. McLean J., Wion K., Drayna D., Fielding C., and Lawn R. Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression. Nucleic Acids Res 14 (1986) 9397-9406
54. Funke H., von Eckardstein A., Pritchard P.H., et al. Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity of this disease. J Clin Invest 91 (1993) 677-683
55. Kuivenhoven J.A., Pritchard H., Hill J., Frohlich J., Assmann G., and Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 38 (1997) 191-205
56. Miida T., Zhang B., Obayashi K., et al. T13 mutation of lecithin-cholesterol acyltransferase gene causes fish-eye disease. Clin Chim Acta 343 (2004) 201-208
57. Klein H.G., Lohse P., Pritchard P.H., Bojanovski D., Schmidt H., and Brewer Jr. H.B. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123⇒Ile) and lecithin-cholesterol acyltransferase (Thr347⇒Met). J Clin Invest 89 (1992) 499-506
58. Fredrickson D.S., Altrocchi P.H., Avioli L.V., Goodman D.S., and Goodman H.C. Tangier disease. Ann Intern Med 55 (1961) 1016-1031
59. Asztalos B.F., Brousseau M.E., McNamara J.R., Horvath K.V., Roheim P.S., and Schaefer E.J. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis 156 (2001) 217-225
60. Bodzioch M., Orso E., Klucken J., et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22 (1999) 347-351
61. Assman G., Von Eckardstein A., and Brewer Jr. H.B. Familial high density lipoprotein deficiency: Tangier disease. In: Scriver C.R., Beaydet A.L., Sly W.S., and Valle D. (Eds). The Metabolic Basis of Inherited Disease. 7th ed. (1995), McGraw-Hill, New York 2053-2072
62. Serfaty-Lacrosniere C., Civeira F., Lanzberg A., et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 107 (1994) 85-98
63. Clee S.M., Kastelein J.J., van Dam M., et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 106 (2000) 1263-1270
64. Slatter T.L., Williams M.J., Frikke-Schmidt R., Tybjaerg-Hansen A., Morison I.M., and McCormick S.P. Promoter haplotype of new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia. Atherosclerosis 187 (2006) 393-400
65. Alrasadi K., Ruel I.L., Marcil M., and Genest J. Functional mutations of the ABCA1 gene in subjects of French-Canadian descent with HDL deficiency. Atherosclerosis 188 (2006) 281-291
66. Tan J.H., Low P.S., Tan Y.S., et al. ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore. Hum Genet 113 (2003) 106-117
67. Reilly M.P., Foulkes A.S., Wolfe M.L., and Rader D.J. Higher-order lipase gene association with plasma triglycerides. J Lipid Res 46 (2005) 1914-1922
68. Patsch J.R., Prasad S., Gotto Jr. A.M., and Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80 (1987) 341-347
69. Goldberg I.J., Blaner W.S., Vanni T.M., Moukides M., and Ramakrishnan R. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoproteins metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest 86 (1990) 463-473
70. Frenais R., Nazih H., Ouguerram K., et al. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus. J Clin Endocrinol Metab 86 (2001) 1962-1967
71. Brinton E.A., Eisenberg S., and Breslow J.L. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein- cholesterol levels with or without hypertriglyceridemia. J Clin Invest 87 (1991) 536-544
72. Ruel I.L., Gaudet D., Perron P., et al. Determinants of HDL particle size in patients with the null (P207L) or defective (D9N) mutation in the lipoprotein lipase gene: the Quebec LipD Study. Atherosclerosis 162 (2002) 269-276
73. Wittrup H.H., Tybjaerg-Hansen A., Abildgaard S., Steffensen R., Schnohr P., and Nordestgaard B.G. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest 99 (1997) 1606-1613
74. Durrington P. Dyslipidemia. Lancet 362 (2003) 717-731
75. Siafakas C.G., Brown M.R., and Miller T.L. Neonatal pancreatitis associated with familial lipoprotein lipase deficiency. J Pediatr Gastroenterol Nutr 29 (1999) 95-98
76. Benlian P., De Gennes J.L., Foubert L., Zhang H., Gagne S.E., and Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 335 (1996) 848-854
77. Brunzell J.D., Albers J.J., Chait A., Grundy S.M., Groszek E., and McDonald G.B. Plasma lipoproteins in familial combined hyperlipidemia and mongenic familial hypertriglyceridemia. J Lipid Res 24 (1983) 147-155
78. Ama P.F., Poehlman E.T., Simoneau J.A., et al. Fat distribution and adipose tissue metabolism in non-obese male black African and Caucasian subjects. Int J Obes 10 (1986) 503-510
79. Yamashita S., Maruyama T., Hirano K., Sakai N., Nakajima N., and Matsuzawa Y. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. Atherosclerosis 152 (2000) 271-285
80. Glueck C.J., Gartside P., Fallat R.W., Sielski J., and Steiner P.M. Longevity syndromes; familial hypobeta and familial hyperalpha lipoproteinemia. J Lab Clin Med 88 (1976) 941-957
81. Matsuzawa Y., Yamashita S., Kameda K., Kubo M., Tarui S., and Hara I. Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity; a case report. Atherosclerosis 53 (1984) 207-212
82. Schmidt H.H., Gregg R.E., Tietge U.J., et al. Upregulated synthesis of both apolipoprotein A-I and apolipoprotein B in familial hyperalphalipoproteinemia and hyperbetalipoproteinemia. Metabolism 47 (1998) 1160-1166
83. Drayna D., Jarnagin A.S., McLean J., et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327 (1987) 632-634
84. Barter P.J., Brewer Jr. H.B., Chapman M.J., Hennekens C.H., Rader D.J., and Tall A.R. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 23 (2003) 160-167
85. Ikewaki K., Rader D.J., Sakamoto T., et al. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest 92 (1993) 1650-1658
86. Inazu A., Brown M.L., Hesler C.B., et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323 (1990) 1234-1238
87. Nagano M., Nakamura M., Kobayashi N., Kamata J., and Hiramori K. Effort angina in middle-aged woman with abnormally high levels of serum high-density lipoprotein cholesterol: a case of cholesteryl-ester transfer protein deficiency. Circ J 69 (2005) 609-612
88. Hirano K., Yamashita S., Nakajima N., et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol 17 (1997) 1053-1059
89. Zhong S., Sharp D.S., Grove J.S., et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97 (1996) 2917-2923
90. Agerholm-Larsen B., Nordestgaard B.G., Steffensen R., Jensen G., and Tybjaerg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesterol ester transfer protein gene. Circulation 101 (2000) 1907-1912
91. De Grooth G.J., Klerkx A.H., Stroes E.S., Stalenhoef A.F., Kastelein J.J., and Kuivenhoven J.A. A review of CETP and its relation to atherosclerosis. J Lipid Res 45 (2004) 1967-1974
92. Cohen J.C., Vega G.L., and Grundy S.M. Hepatic lipase: new insights from genetic and metabolic studies. Curr Opin Lipidol 10 (1999) 259-267
93. Connelly P.W., and Hegele R.A. Hepatic lipase deficiency. Crit Rev Clin Lab Sci 35 (1998) 547-572
94. Kuusi T., Saarinen P., and Nikkila E.A. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis 36 (1980) 589-593
95. Lamarche B., Uffelman K.D., Carpentier A., et al. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 103 (1999) 1191-1199
96. Ruel I.L., Couture P., Cohn J.S., Bensadoun A., Marcil M., and Lamarche B. Evidence that hepatic lipase in humans is not associated with proatherogenic changes in HDL composition and metabolism. J Lipid Res 45 (2004) 1528-1537
97. Tilly-Kiesi M., Schaefer E.J., Knudsen P., et al. Lipoprotein metabolism in subjects with hepatic lipase deficiency. Metabolism 53 (2004) 520-525
98. Hegele R.A., Little J.A., Vezina C., et al. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 13 (1993) 720-728
99. Hsu L.A., Ko Y.L., Wu S., et al. Association between a novel 11 base-pair deletion mutation in the promoter region of scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese. Arterioscler Thromb Vasc Biol 23 (2003) 1869-1874
100. Acton S., Osgood D., Donoghue M., et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 19 (1999) 1734-1743
101. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
102. Rothblat G.H., de la Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., and Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 40 (1999) 781-796
103. Kozarsky K.F., Donahee M.H., Rigotti A., Iqbal S.N., Edelman E.R., and Krieger M. Overexpression of the HDL receptor SR-BI alter plasma HDL and bile cholesterol levels. Nature 387 (1997) 414-417
104. Varban M.L., Rinninger F., Wang N., et al. Targeted mutation reveals a central role of SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 95 (1998) 4619-4624
105. Trigatti B., Rayburn H., Vinals M., et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A 96 (1999) 9322-9327
106. Braun A., Trigatti B.L., Post M.J., et al. Loss of SR-BI expression leads to early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 90 (2002) 270-276
107. Kozarsky K.F., Donahee M.H., Glick J.M., Krieger M., and Rader D.J. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor deficient mouse. Arterioscler Thromb Vasc Biol 20 (2000) 721-727
108. Edwards K.L., Mahaney M.C., Motulsky A.G., and Austin M.A. Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families. Arterioscler Thromb Vasc Biol 19 (1999) 2456-2464
109. Kullo I.J., de Andrade M., Boerwinkle E., McConnell J.P., Kardia S.L., and Turner S.T. Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships. Am J Hypertens 18 (2005) 99-103
110. Morrison J.A., Barton B.A., Biro F.M., and Sprecher D.L. The conjoint trait of low high-density lipoprotein cholesterol and high triglycerides in adolescent black and white males. Metabolism 47 (1998) 514-521
111. Morrison J.A., deGroot I., Edwards B.K., et al. Plasma cholesterol and triglyceride levels in 6,775 school children, ages 6-17. Metabolism 26 (1977) 1199-1211
112. Frerichs R.R., Srinivasan S.R., Webber L.S., and Berenson G.R. Serum cholesterol and triglyceride levels in 3,446 children from a biracial community: the Bogalusa Heart Study. Circulation 54 (1976) 302-309
113. Li Z., McNamara J.R., Fruchart J.C., et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res 37 (1996) 1886-1896
114. Emond M.J., and Zareba W. Prognostic value of cholesterol in women of different ages. J Womens Health 6 (1997) 295-307
115. Muller R., and Buttner P. A critical discussion of intraclass correlation coefficients. Stat Med 13 (1994) 2465-2476
116. Weinberg R., Avet L.M., and Gardner M.J. Estimates of the heritability of serum lipoprotein and lipid concentrations. Clin Genet 9 (1976) 588-592
117. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
118. Bodurtha J.N., Chen C.W., Mosteller M., Nance W.E., Schieken R., and Segrest J. Genetic and environmental contributions to cholesterol and its subfractions in 11-year-old twins. The Medical College of Virginia Twin Study. Arterioscler Thromb 11 (1991) 844-850
119. Heller D.A., de Faire U., Pedersen N.L., Dahlen G., and McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328 (1993) 1150-1156
120. Comuzzie A.G., Rainwater D.L., Blangero J., Mahaney M.C., VandeBerg J.L., and MacCluer J.W. Shared and unique genetic effects among seven HDL phenotypes. Arterioscler Thromb Vasc Biol 17 (1997) 859-864
121. Hunt S.C., Hasstedt S.J., Kuida H., Stults B.M., Hopkins P.N., and Williams R.R. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids and body mass index in Utah pedigrees and twins. Am J Epidemiol 129 (1989) 625-638
122. Knoblauch H., Busjahn A., Münter S., et al. Heritability analysis of lipids and three gene loci in twins link the macrophage scavenger receptor to HDL cholesterol concentrations. Arterioscler Thromb Vasc Biol 17 (1997) 2054-2060
123. Boomsma D.I., Kempen H.J., Gevers Leuven J.A., Havekes L., de Knijff P., and Frants R.R. Genetic analysis of sex and generation differences in plasma lipid lipoprotein and apolipoprotein levels in adolescent twins and their parents. Genet Epidemiol 13 (1996) 49-60
124. Snieder H., van Doornen L.J., and Boomsma D.I. The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins. Am J Hum Genet 60 (1997) 638-650
125. Freeman M.S., Mansfield M.W., Barrett J.H., and Grant P.J. Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 19 (2002) 994-999
126. Williams P.D., Puddey I.B., Martin N.G., and Beilin L.J. Genetic and environmental covariance of serum cholesterol and blood pressure in female twins. Atherosclerosis 100 (1993) 19-31